These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 27418566)
1. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability. Pan Y; Tikekar RV; Nitin N Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566 [TBL] [Abstract][Full Text] [Related]
2. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
3. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
4. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828 [TBL] [Abstract][Full Text] [Related]
5. Distribution of encapsulated materials in colloidal particles and its impact on oxidative stability of encapsulated materials. Tikekar RV; Nitin N Langmuir; 2012 Jun; 28(25):9233-43. PubMed ID: 22616688 [TBL] [Abstract][Full Text] [Related]
6. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
8. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790 [TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496 [TBL] [Abstract][Full Text] [Related]
11. Fabrication and characterization of nanostructured lipid carriers (NLC) using a plant-based emulsifier: Quillaja saponin. Kharat M; McClements DJ Food Res Int; 2019 Dec; 126():108601. PubMed ID: 31732055 [TBL] [Abstract][Full Text] [Related]
12. An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Hung LC; Basri M; Tejo BA; Ismail R; Nang HL; Abu Hassan H; May CY Colloids Surf B Biointerfaces; 2011 Oct; 87(1):180-6. PubMed ID: 21652183 [TBL] [Abstract][Full Text] [Related]
13. Preparation of 9 Yang C; Yan H; Jiang X; Xu H; Tsao R; Zhang L J Agric Food Chem; 2020 Nov; 68(47):13844-13853. PubMed ID: 33164495 [No Abstract] [Full Text] [Related]
14. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Uner M Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531 [TBL] [Abstract][Full Text] [Related]
15. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles. Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194 [TBL] [Abstract][Full Text] [Related]
16. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915 [TBL] [Abstract][Full Text] [Related]
17. Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Hejri A; Khosravi A; Gharanjig K; Hejazi M Food Chem; 2013 Nov; 141(1):117-23. PubMed ID: 23768336 [TBL] [Abstract][Full Text] [Related]
18. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment. Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373 [TBL] [Abstract][Full Text] [Related]
19. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
20. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Chen CC; Tsai TH; Huang ZR; Fang JY Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]